Almut Winterstein, PhD, FISPE

Distinguished Professor
University of Florida
Gainesville, Florida, United States

Almut Winterstein received her pharmacy degree from Friedrich Wilhelm University in Bonn, Germany and her PhD in Pharmacoepidemiology from the Charité Humboldt University in Berlin, Germany. She holds the position of Professor and Chair in the Department of Pharmaceutical Outcomes and Policy at the College of Pharmacy and is the founding Director of the Center for Drug Evaluation and Safety, both at the University of Florida. She has an affiliate appointment in the Department of Epidemiology at the Colleges of Medicine and Public Health and Health Professions. In 2017, she was named the Dr. Robert and Barbara Crisafi Chair for Medication Safety in recognition of her research on drug safety and on devising ways to improve medication use.

Since joining the University of Florida in 2000, Winterstein has served as principal investigator on more than 25 extramurally funded grants and contracts and published more than 400 manuscripts and conference abstracts. Her research interests have centered on the post-marketing evaluation of drugs in pediatrics and perinatal care, infectious disease and psychiatry and the evaluation and improvement of quality surrounding medication use using real-world data. As expert in drug safety, she has chaired the Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee from 2012-2018. Recognizing her contributions in pharmacoepidemiology, Dr. Winterstein was inducted as a fellow of the International Society of Pharmacoepidemiology in 2013 and currently serves as president of the society. Before she became department chair, Dr. Winterstein served as graduate program director of her department, which has generated many active ISPE members.

Arbor Pharmaceuticals (Consultant/Advisory Board)Genetech Inc. (Consultant/Advisory Board)Merck, Sharpe, Dohme (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)

Presentation(s):

• Principles of Pharmacoepidemiology

  Wednesday, August 24, 2022
  8:30 AM – 12:30 PM CEST

• Evaluation of Fall-related Injuries Following a Potential Calcium Channel Blocker — Loop Diuretic Prescribing Cascade

  Friday, August 26, 2022
  1:45 PM – 2:00 PM CEST

• Evaluating the Safety of Antiemetic Combination Use on Pregnancy Loss

  Friday, August 26, 2022
  2:00 PM – 2:15 PM CEST

• Safety First!

  Saturday, August 27, 2022
  8:00 AM – 9:30 AM CEST

• Association Between Phentermine and Risk of Major Adverse Cardiovascular Events: A Suite of Self-Controlled and Comparative Cohort Studies to Conquer Confounding

  Saturday, August 27, 2022
  1:45 PM – 2:00 PM CEST

• Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System

  Sunday, August 28, 2022
  9:00 AM – 9:15 AM CEST

• Shaping the Future of Pharmacoepidemiology

  Sunday, August 28, 2022
  10:30 AM – 12:00 PM CEST

• A Translational Approach to Study Drug-Drug Interaction with Hormonal Contraceptives: From Pharmacoepidemiology to Mechanistic Modelling

  Sunday, August 28, 2022
  2:00 PM – 2:15 PM CEST

• Hot Topic Session: How Can We Mitigate Publication of Poorly Conducted RWE Studies? Keynote Session [Plenary]

  Sunday, August 28, 2022
  3:15 PM – 4:45 PM CEST